Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

72.88 +0.34 (+0.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viking Thera

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Why Are Stocks Down Today?
Stocks are down again on Wednesday as investors continue to feel the effects of several major catalysts hitting the market. 
Via InvestorPlace
Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts
Pfizer layoffs are a hot topic among PFE stock traders on Wednesday as they pour over the details of the job cuts amid a Covid slump. 
Via InvestorPlace
Topics Workforce
Exposures COVID-19 Layoff
Why Is Viking Therapeutics (VKTX) Stock Moving Today?
Viking Therapeutics stock is on the move Wednesday as investors react to results from the company's latest clinical trial! 
Via InvestorPlace
Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Gainers Biocept, Inc. (NASDAQ: BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court... 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
2 Magnificient Growth Stocks I'm Buying in August
These biotech stocks could markedly outperform the broader market. 
Via The Motley Fool
9 Analysts Have This to Say About Viking Therapeutics
Via Benzinga
Earnings Preview: Viking Therapeutics
Via Benzinga
Expert Ratings for Viking Therapeutics
Via Benzinga
Jim Carmer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Abbott Laboratories (NYSE: ABT) is a "very good company and will be up to the—let’s say—up to the challenge. I think that’s fair. 
Via Benzinga
Consolidation In Viking Therapeutics Provides An Opportunity
Viking Therapeutics Inc. (VKTX) is an innovative biotechnology company developing novel therapeutics for metabolic and endocrine diseases. 
Via Talk Markets
Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday
U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
3 Biotechs Compete for the Same $108-Billion-Dollar Market. Are They a Buy?
NASH treatments are projected to be one of the most sought-after indications in the coming years. 
Via The Motley Fool
Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It
NASH is a surprisingly common ailment, and the first treatments are on the way. 
Via The Motley Fool
The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Are On Fire Today
Novo Nordisk's popular weight loss drug also confers a significant cardioprotective effect, according to a new study. 
Via The Motley Fool
Lilly Shares Up On Versanis Deal Amid Weight-Loss Drug Gold Rush
A bid to acquire Versanis boosts Eli Lilly & Co. by 2.80% in the past week, as the competition to develop the most effective weight-loss drug intensifies. 
Via MarketBeat
3 Small-Cap Stocks That Could Be Big-Time Winners
These stocks come with significant risks. But they could generate huge returns over time. 
Via The Motley Fool
The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?
An overweight world is hungry for new treatments. For now, two companies own the market. 
Via Investor's Business Daily
3 Top Biotech Stocks Defying the Bear Market
Each has the potential to dramatically outperform the market. 
Via The Motley Fool
2 Hot Stocks Up 30% This Year That Wall Street Thinks Can Still Go Higher
Are analysts right to be so bullish about these stocks? 
Via The Motley Fool
The 3 Best Momentum Stocks to Buy in July
For those who identify the right shares at the right time, the rewards of momentum stocks far outstrip those of their competitors. 
Via InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023
If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead. 
Via InvestorPlace
Better Buy: Nano-X Imaging vs. Viking Therapeutics
Which healthcare stock is the better option for growth investors? 
Via The Motley Fool
Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says
Tuesday, Terns Pharmaceuticals Inc (NASDAQ: TERN) shares lost more than 25% of their value due to investor pressure it faced after Eli Lilly And Co (NYSE: LLY) announced data from retatrutide that was... 
Via Benzinga
Snowflake, Beazer Homes, Joby Aviation And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Viking Therapeutics Is Plunging Today
The biotech's shares are being negatively impacted today by mid-stage data for a competing weight loss drug. 
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. 
Via Benzinga
Why Viking Therapeutics Stock Is Crashing Today
Investors seem concerned about the company's competitive positioning in weight loss. 
Via The Motley Fool
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.